Compugroup Medical SE (ETR:COP) has been given a €52.00 ($59.77) target price by research analysts at Baader Bank in a note issued to investors on Friday. The brokerage currently has a “buy” rating on the stock.
Several other equities analysts have also recently weighed in on COP. Warburg Research set a €52.00 ($59.77) target price on Compugroup Medical SE and gave the company a “neutral” rating in a research note on Thursday, July 13th. HSBC Holdings plc set a €60.00 ($68.97) target price on Compugroup Medical SE and gave the company a “buy” rating in a research note on Wednesday, July 5th. Finally, Deutsche Bank AG set a €60.00 ($68.97) target price on Compugroup Medical SE and gave the company a “buy” rating in a research note on Monday, June 26th.
Compugroup Medical SE (ETR:COP) opened at 50.95 on Friday. Compugroup Medical SE has a one year low of €35.28 and a one year high of €52.80. The stock has a market capitalization of €2.53 billion and a price-to-earnings ratio of 53.69. The stock’s 50 day moving average is €50.12 and its 200 day moving average is €42.29.
ILLEGAL ACTIVITY NOTICE: This report was originally posted by Community Financial News and is owned by of Community Financial News. If you are accessing this report on another website, it was illegally copied and reposted in violation of United States & international copyright and trademark law. The legal version of this report can be read at https://www.com-unik.info/2017/07/18/compugroup-medical-se-cop-pt-set-at-52-00-by-baader-bank.html.
Compugroup Medical SE Company Profile
Compugroup Medical SE is a Germany-based software developer. The Company focuses on software solutions to the healthcare industry, including physicians, pharmacies, health insurances, laboratories, hospitals and rehabilitation and care facilities. Its activities are divided into three segments: Health Provider Services I, Health Provider Services II and Health Connectivity Services.
What are top analysts saying about Compugroup Medical SE? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Compugroup Medical SE and related companies.